{"id":73761,"date":"2025-11-17T11:17:28","date_gmt":"2025-11-17T05:47:28","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=73761"},"modified":"2025-11-17T11:17:28","modified_gmt":"2025-11-17T05:47:28","slug":"global-precision-medicine","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/global-precision-medicine\/","title":{"rendered":"India\u2019s Role in Global Precision Medicine Market &#8211; Explained"},"content":{"rendered":"<h2 style=\"text-align: justify;\"><strong>Precision Medicine Latest News<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The <\/span><b>global precision medicine market<\/b><span style=\"font-weight: 400;\"> is expanding rapidly, projected to cross $22 billion by 2027, with India emerging as a key player.<\/span><\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>Precision Biotherapeutics<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Precision biotherapeutics<\/b><span style=\"font-weight: 400;\"> refers to medical interventions optimised for a patient\u2019s <\/span><b>specific genetic or molecular profile<\/b><span style=\"font-weight: 400;\">, rather than relying on generalised population-level data.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This approach allows for <\/span><b>early diagnosis, personalised treatment<\/b><span style=\"font-weight: 400;\">, and <\/span><b>fewer adverse effects<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Key technologies shaping this field include:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Genomic and Proteomic Analysis:<\/b><span style=\"font-weight: 400;\"> Decoding individual genetic and protein signatures to identify disease-causing mutations.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Gene Editing Therapies:<\/b><span style=\"font-weight: 400;\"> Tools like <\/span><b>CRISPR-Cas9<\/b><span style=\"font-weight: 400;\"> modify defective genes to correct underlying causes of disorders such as <\/span><b>thalassemia<\/b><span style=\"font-weight: 400;\"> and <\/span><b>sickle-cell anaemia<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>mRNA and Nucleic Acid Therapeutics:<\/b><span style=\"font-weight: 400;\"> These therapies, popularised during the COVID-19 pandemic, use RNA molecules to instruct cells to produce or suppress specific proteins.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Monoclonal Antibodies and Biologics:<\/b><span style=\"font-weight: 400;\"> Laboratory-engineered molecules that precisely target disease-related proteins, used in treatments for <\/span><b>cancer, rheumatoid arthritis<\/b><span style=\"font-weight: 400;\">, and <\/span><b>autoimmune diseases<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>AI-Driven Drug Discovery:<\/b><span style=\"font-weight: 400;\"> Machine learning models analyse vast datasets to predict molecule interactions, accelerating the discovery of new drugs.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Together, these technologies represent a shift from <\/span><b>symptom management<\/b><span style=\"font-weight: 400;\"> to <\/span><b>disease correction at the molecular level<\/b><span style=\"font-weight: 400;\">, offering transformative potential for chronic and genetic illnesses.<\/span><\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>The Global Precision Medicine Landscape<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li><span style=\"font-weight: 400;\">The precision medicine industry has seen exponential growth over the past decade.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">According to <\/span><b>Precedence Research<\/b><span style=\"font-weight: 400;\">, the global market, valued at approximately <\/span><b>$12 billion in 2023<\/b><span style=\"font-weight: 400;\">, is expected to surpass <\/span><b>$22 billion by 2027<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li><b>Key drivers of this growth include:<\/b><\/li>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Advances in <\/span><b>next-generation sequencing (NGS)<\/b><span style=\"font-weight: 400;\"> and <\/span><b>gene editing technologies<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Rising prevalence of <\/span><b>non-communicable diseases (NCDs)<\/b><span style=\"font-weight: 400;\"> like cancer, diabetes, and cardiovascular disorders.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Integration of <\/span><b>AI and big data analytics<\/b><span style=\"font-weight: 400;\"> in clinical decision-making.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Increased investment from pharmaceutical and biotech companies in personalised drug development.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The United States, Europe, and China currently lead global innovation in precision medicine.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">However, developing economies like <\/span><b>India<\/b><span style=\"font-weight: 400;\"> and <\/span><b>Brazil<\/b><span style=\"font-weight: 400;\"> are fast emerging as competitive hubs due to their <\/span><b>cost advantage, skilled workforce<\/b><span style=\"font-weight: 400;\">, and <\/span><b>growing genomic research infrastructure<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>India\u2019s Position in the Precision Medicine Ecosystem<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li><span style=\"font-weight: 400;\">India contributes nearly <\/span><b>65% of deaths<\/b><span style=\"font-weight: 400;\"> from <\/span><b>non-communicable diseases<\/b><span style=\"font-weight: 400;\">, underscoring the need for advanced diagnostic and therapeutic approaches.\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">The country\u2019s <\/span><b>diverse genetic landscape<\/b><span style=\"font-weight: 400;\">, one of the most complex in the world, makes it an ideal testing ground for precision biotherapeutics.<\/span><\/li>\n<li aria-level=\"1\"><b>Research and Institutional Strength<\/b>\n<ul>\n<li><span style=\"font-weight: 400;\">The <\/span><b>Department of Biotechnology (DBT)<\/b><span style=\"font-weight: 400;\"> has identified <\/span><b>precision biotherapeutics<\/b><span style=\"font-weight: 400;\"> as one of six focus areas under its <\/span><b>Biotechnology for Economy, Environment, and Employment (BioE3)<\/b><span style=\"font-weight: 400;\"> policy.\u00a0<\/span><\/li>\n<\/ul>\n<\/li>\n<li aria-level=\"1\"><b>Genomic Initiatives and Localisation<\/b>\n<ul>\n<li><span style=\"font-weight: 400;\">Projects like <\/span><b>GenomeIndia<\/b><span style=\"font-weight: 400;\"> and <\/span><b>IndiGen<\/b><span style=\"font-weight: 400;\"> are building reference genomic databases representing India\u2019s vast population diversity.\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Such datasets enable <\/span><b>customisation of global drug molecules<\/b><span style=\"font-weight: 400;\"> to Indian genetic profiles, addressing the common issue where <\/span><b>foreign-developed drugs<\/b><span style=\"font-weight: 400;\"> show <\/span><b>reduced efficacy<\/b><span style=\"font-weight: 400;\"> among Indian patients.<\/span><\/li>\n<\/ul>\n<\/li>\n<li aria-level=\"1\"><b>Challenges Hindering India\u2019s Precision Medicine Growth<\/b>\n<ul>\n<li><b>Regulatory Gaps:<\/b><span style=\"font-weight: 400;\"> There is no unified framework governing gene and cell therapies. Current regulations are fragmented and unclear on therapeutic use.<\/span><\/li>\n<li><b>High Cost and Limited Access:<\/b><span style=\"font-weight: 400;\"> Advanced biotherapeutics remain <\/span><b>affordable only to urban elite<\/b><span style=\"font-weight: 400;\">, with costs running into lakhs per treatment.<\/span><\/li>\n<li><b>Manufacturing Bottlenecks:<\/b><span style=\"font-weight: 400;\"> India lacks large-scale facilities for biologics and cell-based therapies, forcing dependence on imports.<\/span><\/li>\n<li><b>Ethical and Data Privacy Concerns:<\/b><span style=\"font-weight: 400;\"> Genomic data, if not protected by robust <\/span><b>data protection laws and consent frameworks<\/b><span style=\"font-weight: 400;\">, risks misuse and discrimination.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Addressing these gaps is crucial for India to emerge as a trusted global leader in <\/span><b>affordable precision healthcare<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>Opportunities for Growth<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400; text-align: justify;\" aria-level=\"1\"><span style=\"font-weight: 400;\">India\u2019s advantages lie in its <\/span><b>cost-effective research environment<\/b><span style=\"font-weight: 400;\">, <\/span><b>data analytics capabilities<\/b><span style=\"font-weight: 400;\">, and <\/span><b>biotechnology talent pool<\/b><span style=\"font-weight: 400;\">.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400; text-align: justify;\" aria-level=\"1\"><span style=\"font-weight: 400;\">By fostering <\/span><b>public-private partnerships<\/b><span style=\"font-weight: 400;\">, strengthening <\/span><b>biomanufacturing infrastructure<\/b><span style=\"font-weight: 400;\">, and creating <\/span><b>ethical genomic data-sharing frameworks<\/b><span style=\"font-weight: 400;\">, India can:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Localise global therapies at lower costs.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Expand precision medicine access to rural populations.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Attract international investment in <\/span><b>R&amp;D and clinical trials<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400; text-align: justify;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Collaborations with global institutions, coupled with government support under <\/span><b>\u2018Make in India\u2019 for Biotech<\/b><span style=\"font-weight: 400;\">, could position India as a <\/span><b>global hub for precision therapeutics<\/b><span style=\"font-weight: 400;\"> in the next decade.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><b>Source :<\/b> <a href=\"https:\/\/www.thehindu.com\/sci-tech\/science\/precision-biotherapeutics-explained\/article70288204.ece\" target=\"_blank\" rel=\"nofollow noopener\"><span style=\"font-weight: 400;\">TH<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The global precision medicine market is set to surpass $22 billion by 2027, with India positioning itself as a hub.<\/p>\n","protected":false},"author":21,"featured_media":73765,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[60,3738,22,59],"class_list":{"0":"post-73761","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-upsc-mains-current-affairs","8":"tag-mains-articles","9":"tag-precision-medicine","10":"tag-upsc-current-affairs","11":"tag-upsc-mains-current-affairs","12":"no-featured-image-padding"},"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/73761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=73761"}],"version-history":[{"count":0,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/73761\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/73765"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=73761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=73761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=73761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}